ALSERES PHARMACEUTICALS INC /DE Increase (Decrease) in Deferred Revenue
ALSERES PHARMACEUTICALS INC /DE reported Increase (Decrease) in Deferred Revenue of -$36.86 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2014-08-14
- ALSERES PHARMACEUTICALS INC /DE increase (decrease) in deferred revenue for the quarter ending 2014-06-30 was -$18.43K.
- ALSERES PHARMACEUTICALS INC /DE increase (decrease) in deferred revenue for the quarter ending 2014-03-31 was -$18.43K.
- ALSERES PHARMACEUTICALS INC /DE increase (decrease) in deferred revenue for the quarter ending 2013-12-31 was -$18.43K, a 147.43% decline year-over-year.
- ALSERES PHARMACEUTICALS INC /DE increase (decrease) in deferred revenue for the quarter ending 2013-09-30 was -$18.43K.
- ALSERES PHARMACEUTICALS INC /DE increase (decrease) in deferred revenue for fiscal 2013 was -$73.73K, a 136.58% decline from fiscal 2012.
- ALSERES PHARMACEUTICALS INC /DE increase (decrease) in deferred revenue for fiscal 2012 was $201.58K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 233 month | Increase (Decrease) in Deferred Revenue 239 month | Increase (Decrease) in Deferred Revenue 242 month | Increase (Decrease) in Deferred Revenue 245 month | Increase (Decrease) in Deferred Revenue 248 month | Increase (Decrease) in Deferred Revenue 251 month | Increase (Decrease) in Deferred Revenue 254 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | -$18.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$36.86K 10-Q · filed 2014-08-14 | -$55.30K derived: sum of 3 quarters · filed 2014-08-14 | -$73.73K derived: sum of 4 quarters · filed 2014-08-14 | |||||||
| 2014-03-31 | -$18.43K 10-Q · filed 2014-05-23 | -$36.86K derived: sum of 2 quarters · filed 2014-05-23 | -$55.30K derived: sum of 3 quarters · filed 2014-05-23 | -$73.73K derived: sum of 4 quarters · filed 2014-08-14 | |||||||
| 2013-12-31 | -$18.43K derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-10 | -$36.87K derived: sum of 2 quarters · filed 2014-04-10 | -$55.30K derived: sum of 3 quarters · filed 2014-08-14 | -$73.73K 10-K · filed 2014-04-10 | $127.85K 10-K · filed 2014-04-10 | ||||||
| 2013-09-30 | -$18.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$36.86K derived: sum of 2 quarters · filed 2014-08-14 | -$55.30K 10-Q · filed 2013-11-14 | -$16.43K derived: sum of 4 quarters · filed 2014-08-14 | $146.28K 10-Q · filed 2013-11-14 | ||||||
| 2013-06-30 | -$18.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$36.86K 10-Q · filed 2014-08-14 | $2.00K derived: sum of 3 quarters · filed 2014-08-14 | $164.71K 10-Q · filed 2013-08-09 | |||||||
| 2013-03-31 | -$18.43K 10-Q · filed 2014-05-23 | $20.43K derived: sum of 2 quarters · filed 2014-05-23 | $183.15K 10-Q · filed 2013-05-17 | ||||||||
| 2012-12-31 | $38.87K derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-10 | $201.58K 10-K · filed 2014-04-10 | $201.58K 10-K · filed 2013-04-01 | ||||||||
| 2012-09-30 | $162.71K 10-Q · filed 2013-11-14 | $162.71K 10-Q · filed 2012-11-14 | |||||||||
| 2012-03-31 | $250.00K 10-Q · filed 2013-05-17 | $250.00K 10-Q · filed 2012-05-11 |